EEG-Biocontrol Method in Treating the Attention Deficit Hyperactivity Disorder in Children

The problems of epidemiology, etiology, pathogenesis, and clinical signs of attention deficit hyperactivity disorder (ADHD) in children were considered. The literature review of the EEG-biocontrol method in treating ADHD in children, including the background, the theoretical basis of the method, and the assessment of its effectiveness, is presented. Specific features of the EEG-biocontrol protocols based on the data of different authors are given. The comparative assessment of the efficacy of EEG-biocontrol and drug treatment with the use of psychostimulants in ADHD is presented.

[1]  J. Biederman,et al.  Pharmacotherapy of attention deficit hyperactivity disorder. , 2000, Child and adolescent psychiatric clinics of North America.

[2]  A. King,et al.  Cerebral glucose metabolism in adults with attention deficit hyperactivity disorder after chronic stimulant treatment. , 1994, The American journal of psychiatry.

[3]  C. Gillberg,et al.  Children with deficits in attention, motor control and perception (DAMP) almost grown up: psychiatric and personality disorders at age 16 years. , 1994, Journal of child psychology and psychiatry, and allied disciplines.

[4]  P. Renshaw,et al.  Volumetric MRI analysis comparing subjects having attention-deficit hyperactivity disorder with normal controls , 1997, Neurology.

[5]  N J Cox,et al.  Association of attention-deficit disorder and the dopamine transporter gene. , 1995, American journal of human genetics.

[6]  M. Sterman,et al.  Instrumental conditioning of sensorimotor cortex EEG spindles in the waking cat. , 1968 .

[7]  W. Iacono,et al.  Twin concordance for attention deficit hyperactivity disorder: a comparison of teachers' and mothers' reports. , 1997, The American journal of psychiatry.

[8]  S. Hinshaw,et al.  Initial sociometric impressions of attention-deficit hyperactivity disorder and comparison boys: predictions from social behaviors and from nonbehavioral variables. , 1994, Journal of consulting and clinical psychology.

[9]  S C Suffin,et al.  Neurometric Subgroups in Attentional and Affective Disorders and Their Association with Pharmacotherapeutic Outcome , 1995, Clinical EEG.

[10]  A. Abarbanel.  Gates, States, Rhythms, and Resonance: The Scientific Basis for Neurofeedback Training , 1995 .

[11]  P. Ahmann,et al.  Placebo-controlled evaluation of Ritalin side effects. , 1993, Pediatrics.

[12]  M. Abarbanel,et al.  Gates, States, Rhythms, and Resonance: , 1995 .

[13]  S C Schneider,et al.  Attention-deficit hyperactivity disorder. In pursuit of diagnostic accuracy. , 1997, Postgraduate medicine.

[14]  J. Rapoport,et al.  Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. , 1996, Archives of general psychiatry.

[15]  J. Olds.  Hypothalamic substrates of reward. , 1962, Physiological reviews.

[16]  Maj. Larry C. James,et al.  Biofeedback—A Practitioner's Guide. 2nd ed. , 1997 .

[17]  T Janzen,et al.  Differences in baseline EEG measures for ADD and Normally Achieving preadolescent males , 1995, Biofeedback and self-regulation.

[18]  H. Engeland,et al.  Methylphenidate influences on both early and late ERP waves of ADHD children in a continuous performance test , 1994, Journal of abnormal child psychology.

[19]  Michael Linden,et al.  A controlled study of the effects of EEG biofeedback on cognition and behavior of children with attention deficit disorder and learning disabilities , 1996 .

[20]  D. Javitt,et al.  MISMATCH NEGATIVITY IN HYPERACTIVE CHILDREN:EFFECTS OF METHYLPHENIDATE , 1993, Psychopharmacology bulletin.

[21]  C. Whalen,et al.  Attention Deficit and Hyperactivity Disorders , 1989 .

[22]  Thomas R. Rossiter,et al.  A Comparison of EEG Biofeedback and Psychostimulants in Treating Attention Deficit/Hyperactivity Disorders , 1995 .

[23]  J. Satterfield.  EEG issues in children with minimal brain dysfunction. , 1973, Seminars in psychiatry.

[24]  J. Sverd,et al.  School Observations of Children with Attention‐Deficit Hyperactivity Disorder and Comorbid Tic Disorder: Effects of Methylphenidate Treatment , 1995, Journal of developmental and behavioral pediatrics : JDBP.

[25]  J. Krystal,et al.  Psychopharmacology: The Third Generation of Progress , 1989, The Yale Journal of Biology and Medicine.

[26]  J. Rapoport,et al.  Quantitative morphology of the caudate nucleus in attention deficit hyperactivity disorder. , 1994, The American journal of psychiatry.

[27]  D. Javitt,et al.  Electrophysiological indices of information processing in methylphenidate responders , 1997, Biological Psychiatry.

[28]  J G Simeon,et al.  Pharmacotherapy of Attention-Deficit Hyperactivity Disorder , 1993, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[29]  J. Lubar,et al.  Electroencephalographic biofeedback of SMR and beta for treatment of attention deficit disorders in a clinical setting , 1984, Biofeedback and self-regulation.

[30]  M. Tansey,et al.  Ten-year stability of EEG biofeedback results for a hyperactive boy who failed fourth grade perceptually impaired class , 1993, Biofeedback and self-regulation.

[31]  S. Sandberg.  Hyperkinetic or Attention Deficit Disorder , 1996, British Journal of Psychiatry.

[32]  J. Lubar.  Discourse on the development of EEG diagnostics and biofeedback for attention-deficit/hyperactivity disorders , 1991, Biofeedback and self-regulation.

[33]  J. Swanson,et al.  Effects of Methylphenidate on Impulsive Responding in Children With Attention-Deficit Hyperactivity Disorder , 1993, Journal of child neurology.

[34]  E. Heiligenstein,et al.  Pemoline therapy in college students with attention deficit hyperactivity disorder: a retrospective study. , 1996, Journal of American college health : J of ACH.

[35]  M. Taylor,et al.  Effects of methylphenidate in children with attention deficit hyperactivity disorder: a comparison of event-related potentials between medication responders and non-responders. , 1997, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

[36]  J. Swanson,et al.  Hemispheric Processing and Methylphenidate Effects in Attention-Deficit Hyperactivity Disorder , 1994, Journal of child neurology.

[37]  E P Noble,et al.  Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. , 1991, Archives of general psychiatry.

[38]  M. Berkovitch,et al.  BAEP STUDIES IN CHILDREN WITH ATTENTION DEFICIT DISORDER , 1995, Developmental medicine and child neurology.

[39]  M. Taylor,et al.  Changes in event-related potentials with stimulant medication in children with attention deficit hyperactivity disorder , 1993, Biological Psychology.

[40]  R. Dean,et al.  Utilization of maternal perinatal risk indicators in the differential diagnosis of ADHD and UADD children. , 1995, International Journal of Neuroscience.